Polaris Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21M | Sell |
71,641
-2,300
| -3% | -$756K | 1.72% | 28 |
|
|
2025
Q4 | $25.9M | Sell |
73,941
-10,000
| -12% | -$3.38M | 2.15% | 24 |
|
|
2025
Q3 | $27.1M | Buy |
83,941
+22,800
| +37% | +$7.09M | 1.78% | 30 |
|
|
2025
Q2 | $23.8M | Sell |
61,141
-4,000
| -6% | -$1.61M | 1.58% | 33 |
|
|
2025
Q1 | $28.3M | Sell |
65,141
-8,028
| -11% | -$3.22M | 1.62% | 31 |
|
|
2024
Q4 | $27M | Buy |
73,169
+400
| +0.5% | +$167K | 1.3% | 36 |
|
|
2024
Q3 | $37.8M | Sell |
72,769
-600
| -0.8% | -$321K | 1.86% | 22 |
|
|
2024
Q2 | $39.8M | Sell |
73,369
-2,200
| -3% | -$1.16M | 2.13% | 16 |
|
|
2024
Q1 | $39.2M | Sell |
75,569
-10,700
| -12% | -$5.32M | 1.95% | 16 |
|
|
2023
Q4 | $40.7M | Sell |
86,269
-400
| -0.5% | -$185K | 1.96% | 21 |
|
|
2023
Q3 | $37.7M | Sell |
86,669
-36,800
| -30% | -$16.7M | 2.03% | 18 |
|
|
2023
Q2 | $54.9M | Sell |
123,469
-962
| -0.8% | -$444K | 2.06% | 18 |
|
|
2023
Q1 | $57.2M | Buy |
124,431
+200
| +0.2% | +$95.2K | 2.13% | 13 |
|
|
2022
Q4 | $63.7M | Sell |
124,231
-4,420
| -3% | -$2.24M | 2.22% | 10 |
|
|
2022
Q3 | $58.4M | Sell |
128,651
-2,300
| -2% | -$1.1M | 2.29% | 9 |
|
|
2022
Q2 | $63.2M | Sell |
130,951
-2,800
| -2% | -$1.39M | 2.26% | 8 |
|
|
2022
Q1 | $65.7M | Sell |
133,751
-6,500
| -5% | -$2.97M | 2.09% | 10 |
|
|
2021
Q4 | $65M | Sell |
140,251
-1,300
| -0.9% | -$547K | 2.1% | 17 |
|
|
2021
Q3 | $52.8M | Sell |
141,551
-500
| -0.4% | -$190K | 1.68% | 23 |
|
|
2021
Q2 | $54.2M | Buy |
142,051
+1,900
| +1% | +$726K | 1.75% | 22 |
|
|
2021
Q1 | $56.3M | Sell |
140,151
-10,900
| -7% | -$3.51M | 1.85% | 20 |
|
|
2020
Q4 | $48.5M | Buy |
151,051
+100
| +0.1% | +$30.7K | 1.82% | 21 |
|
|
2020
Q3 | $40.5M | Buy |
150,951
+76,257
| +102% | +$20.5M | 2% | 17 |
|
|
2020
Q2 | $19.6M | Buy |
74,694
+5,300
| +8% | +$1.41M | 0.97% | 36 |
|
|
2020
Q1 | $15.8M | Sell |
69,394
-137,600
| -66% | -$37.5M | 0.95% | 37 |
|
|
2019
Q4 | $62.5M | Buy |
206,994
+4,174
| +2% | +$1.15M | 2.58% | 9 |
|
|
2019
Q3 | $48.7M | Buy |
202,820
+1,200
| +0.6% | +$329K | 2.19% | 14 |
|
|
2019
Q2 | $56.9M | Buy |
201,620
+600
| +0.3% | +$164K | 2.4% | 7 |
|
|
2019
Q1 | $57.7M | Sell |
201,020
-5,400
| -3% | -$1.56M | 2.4% | 8 |
|
|
2018
Q4 | $54.2M | Buy |
206,420
+4,300
| +2% | +$1.18M | 2.48% | 7 |
|
|
2018
Q3 | $55.4M | Buy |
202,120
+10,124
| +5% | +$2.63M | 2.41% | 7 |
|
|
2018
Q2 | $45.7M | Sell |
191,996
-91,700
| -32% | -$21.2M | 2.11% | 12 |
|
|
2018
Q1 | $62.3M | Buy |
283,696
+61,900
| +28% | +$14.5M | 2.3% | 15 |
|
|
2017
Q4 | $49.9M | Buy |
221,796
+6,300
| +3% | +$1.34M | 2.33% | 12 |
|
|
2017
Q3 | $40.9M | Buy |
215,496
+16,600
| +8% | +$3.16M | 2.29% | 12 |
|
|
2017
Q2 | $37.4M | Sell |
198,896
-200
| -0.1% | -$35.9K | 2.2% | 12 |
|
|
2017
Q1 | $32.9M | Buy |
199,096
+300
| +0.2% | +$47.7K | 2.34% | 12 |
|
|
2016
Q4 | $28.6M | Buy |
198,796
+51,400
| +35% | +$6.88M | 1.85% | 24 |
|
|
2016
Q3 | $18.5M | Buy |
147,396
+1,200
| +0.8% | +$155K | 1.44% | 26 |
|
|
2016
Q2 | $19.2M | Buy |
146,196
+1,000
| +0.7% | +$137K | 1.67% | 19 |
|
|
2016
Q1 | $20.4M | Buy |
145,196
+14,600
| +11% | +$1.95M | 1.76% | 18 |
|
|
2015
Q4 | $18.2M | Buy |
130,596
+21,074
| +19% | +$2.9M | 1.84% | 10 |
|
|
2015
Q3 | $15.3M | Buy |
109,522
+7,000
| +7% | +$1.05M | 1.86% | 9 |
|
|
2015
Q2 | $16.8M | Hold |
102,522
| – | – | 2.07% | 8 |
|
|
2015
Q1 | $15.8M | Sell |
102,522
-9,100
| -8% | -$1.3M | 2.21% | 7 |
|
|
2014
Q4 | $14M | Buy |
+111,622
| New | +$13.8M | 2.35% | 7 |
|
Other funds holding ELV
VCM
VPM
Polaris Capital Management's ELV Position: Q1 2026 in Review
Polaris Capital Management reduced its Elevance Health (ELV) stake by 3.1% in Q1 2026, selling an estimated $756K and leaving 71,641 shares worth $21M. The position accounts for 1.72% of the portfolio, ranked #28.
Polaris Capital Management first reported a position in ELV in Q4 2014 and has held it in 46 quarters since. The position peaked at $65.7M in Q1 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Polaris Capital Management held 71,641 shares of Elevance Health worth $21M as of Q1 2026.
- Polaris Capital Management sold 2,300 Elevance Health shares in Q1 2026, an estimated $756K.
- Elevance Health made up 1.72% of Polaris Capital Management's portfolio in Q1 2026, its #28 holding.
- Polaris Capital Management first reported a position in Elevance Health in Q4 2014 and has held it in 46 quarters since.
- Polaris Capital Management's Elevance Health position peaked at $65.7M in Q1 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Polaris Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.